Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies

Autor:	Zinzani, Pier Luigi Santoro, Armando Mollica, Luigina Leppa, Sirpa Follows, George A. Lenz, Georg Kim, Won Seog and Nagler, Arnon Panayiotidis, Panayiotis Demeter, Judit and Morschhauser, Franck Munoz, Javier Miriyala, Ashok Benson, Alice Garcia-Vargas, Jose Childs, Barrett H. Dreyling, Martin
Jazyk:	angličtina
Rok vydání:	2019
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::a33f90659ad4e8c8bb155a4a0d1b3406 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3187750 Zobrazit plný text záznamu